153 related articles for article (PubMed ID: 11000994)
1. Autologous peripheral blood haematopoietic stem cell transplantation for chronic myelogenous leukaemia.
Carella AM; Cavalierè M; Lerma E; Corsetti MT
Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):209-17. PubMed ID: 11000994
[TBL] [Abstract][Full Text] [Related]
2. Autografting in chronic myeloid leukemia.
Carella AM; Beltrami G; Corsetti MT
Semin Hematol; 2003 Jan; 40(1):72-8. PubMed ID: 12563613
[TBL] [Abstract][Full Text] [Related]
3. Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon.
Hernández-Boluda JC; Carreras E; Cervantes F; Marín P; Arellano-Rodrigo E; Rovira M; Solé F; Lloveras E; Espinet B; Ocejo A; Montserrat E
Haematologica; 2002 Jan; 87(1):17-22. PubMed ID: 11801461
[TBL] [Abstract][Full Text] [Related]
4. New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia.
Carella AM; Frassoni F; Melo J; Sawyers C; Eaves C; Eaves A; Apperley J; Tura S; Hehlmann R; Reiffers J; Lerma E; Goldman J
Haematologica; 1997; 82(4):478-95. PubMed ID: 9299869
[TBL] [Abstract][Full Text] [Related]
5. Collection of Ph-negative progenitor cells from Ph+ CML patients in complete cytogenetic remission after long-term interferon-alpha therapy.
Russo D; Martinelli G; Montefusco V; Amabile M; Rosti G; Marin L
Haematologica; 1999 Oct; 84(10):953-5. PubMed ID: 10509048
[No Abstract] [Full Text] [Related]
6. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
[TBL] [Abstract][Full Text] [Related]
7. Autologous peripheral blood stem cell transplantation for chronic myelocytic leukaemia, using unmanipulated grafts.
Pigneux A; Mahon FX; Reiffers J
Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):193-8. PubMed ID: 11000992
[TBL] [Abstract][Full Text] [Related]
8. Successful autografting in chronic myelogenous leukaemia using Philadelphia negative blood progenitor cells mobilized with rHuG-CSF alone in a patient responding to alpha-interferon.
Carreras E; Sierra J; Rovira M; Urbano-Ispizua A; Martinez C; Nomdedeu B; Cervantes F; Marín P; Rozman C; Montserrat E
Br J Haematol; 1997 Feb; 96(2):421-3. PubMed ID: 9029037
[TBL] [Abstract][Full Text] [Related]
9. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft.
Corsetti MT; Lerma E; Dejana A; Cavaliere M; Figari O; Vassallo F; Abate M; Luchetti S; Piaggio G; Parodi C; Li Pira G; Manca F; Carella AM
Exp Hematol; 2000 Jan; 28(1):104-11. PubMed ID: 10658682
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte colony-stimulating factor given in addition to interferon-alpha to mobilize peripheral blood stem cells for autologous transplantation in chronic myeloid leukaemia.
Archimbaud E; Michallet M; Philip I; Charrin C; Clapisson G; Belhabri A; Guilhot F; Stryckmans P; Adeleine P; Fière D
Br J Haematol; 1997 Dec; 99(3):678-84. PubMed ID: 9401084
[TBL] [Abstract][Full Text] [Related]
12. Quantitative competitive reverse transcriptase-polymerase chain reaction for BCR-ABL on Philadelphia-negative leukaphereses allows the selection of low-contaminated peripheral blood progenitor cells for autografting in chronic myelogenous leukemia.
Corsetti MT; Lerma E; Dejana A; Basta P; Ferrara R; Benvenuto F; Vassallo F; Abate M; Piaggio G; Parodi C; Sessarego M; Li Pira G; Manca F; Carella AM
Leukemia; 1999 Jul; 13(7):999-1008. PubMed ID: 10400414
[TBL] [Abstract][Full Text] [Related]
13. Mobilisation and reinfusion of Philadelphia negative peripheral blood mononuclear cells in chronic myeloid leukaemia with hydroxyurea and G-CSF.
Johnson RJ; Smith GM
Leuk Lymphoma; 1997 Nov; 27(5-6):401-15. PubMed ID: 9477122
[TBL] [Abstract][Full Text] [Related]
14. High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of hematopoietic regeneration.
Petzer AL; Hochenburger E; Haun M; Duba HCh; Grünewald K; Hoflehner E; Sill H; Linkesch W; Gastl G; Gunsilius E
J Hematother Stem Cell Res; 2002 Apr; 11(2):293-300. PubMed ID: 11983100
[TBL] [Abstract][Full Text] [Related]
15. Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-alpha.
Michallet M; Thiébaut A; Philip I; Charrin C; Vigouroux C; Thomas X; Bilger K; Belhabri A; Guyotat D; Corront B; Salles B; Dumontet C; Péaud PY; Vilque JP; Devidas A; Fière D
Leukemia; 2000 Dec; 14(12):2064-9. PubMed ID: 11187894
[TBL] [Abstract][Full Text] [Related]
16. Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia.
Carella AM; Cunningham I; Lerma E; Dejana A; Benvenuto F; Podestà M; Celesti L; Chimirri F; Abote M; Vassallo F; Figari O; Parodi C; Sessarego M; Valbonesi M; Carlier P; Prencipe E; Gatti AM; van den Berg D; Hoffman R; Frassoni F
J Clin Oncol; 1997 Apr; 15(4):1575-82. PubMed ID: 9193355
[TBL] [Abstract][Full Text] [Related]
17. Autografting for CML--overview and perspectives.
Goldman JM
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S71-4. PubMed ID: 8769708
[No Abstract] [Full Text] [Related]
18. [Autologous transplantation of Ph-negative peripheral blood stem cells for treatment of chronic myelogenous leukemia].
Hatsuse M; Okano A; Okamoto A; Shimura K; Takahashi R; Hirai H; Ashihara E; Inaba T; Fujita N; Shimazaki C; Nakagawa M
Rinsho Ketsueki; 2000 Aug; 41(8):671-5. PubMed ID: 11020996
[TBL] [Abstract][Full Text] [Related]
19. Mobilization of Philadelphia-negative peripheral blood progenitor cells with chemotherapy and rhuG-CSF in chronic myelogenous leukaemia patients with a poor response to interferon-alpha.
Carella AM; Simonsson B; Link H; Lennard A; Boogaerts M; Gorin NC; Tomas-Martinez JF; Dabouz-Harrouche F; Gautier L; Badri N
Br J Haematol; 1998 Apr; 101(1):111-8. PubMed ID: 9576191
[TBL] [Abstract][Full Text] [Related]
20. Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosis.
Sureda A; Petit J; Brunet S; Boqué C; Aventín A; Martino R; González JR; Amill B; Larriba I; Blanco A; Martín-Henao GA; Sierra J; Grañena A
Bone Marrow Transplant; 1999 Dec; 24(12):1285-90. PubMed ID: 10627636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]